RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Revolution Medicines Stock

Revolution Medicines Liabilities 2025

Revolution Medicines Liabilities

293.1 M USD

Ticker

RVMD

ISIN

US76155X1000

WKN

A2PYWG

In 2025, Revolution Medicines's total liabilities amounted to 293.1 M USD, a 24.45% difference from the 235.51 M USD total liabilities in the previous year.

Revolution Medicines Aktienanalyse

What does Revolution Medicines do?

Revolution Medicines Inc is a biotechnology company specializing in the development of cancer medications. It was founded in 2014 in Redwood City, California. The company has received significant investment amounts in recent years and is focused on researching and developing personalized cancer therapies that act on a molecular level. They employ a new method called "in-situ imaging" for faster and more precise identification of treatment options. Revolution Medicines is divided into various areas including research and development of new drugs, collaboration with external partners, and conducting their own testing procedures. Their products include a variety of tailored cancer therapies, with RMC-4630 being one of their most promising therapies for advanced breast cancer. They have more products in development and aim to expand their development opportunities through partnerships with other companies in the cancer research field. This company aims to revolutionize cancer research by developing targeted therapies customized to meet individual patient needs, utilizing innovative methods and technologies. However, they face challenges in understanding and treating the complexity of molecular processes in cancer cells, as well as competition in the field. Overall, Revolution Medicines is a biotechnology company focused on shaping the future of cancer research. Revolution Medicines ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Revolution Medicines's Liabilities

Revolution Medicines's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Revolution Medicines's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Revolution Medicines's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Revolution Medicines's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Revolution Medicines’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Revolution Medicines stock

What is the level of liabilities of Revolution Medicines this year?

Revolution Medicines has a debt balance of 293.1 M USD this year.

What were the liabilities of Revolution Medicines compared to the previous year?

The liabilities of Revolution Medicines have increased by 24.45% increased compared to the previous year.

What are the consequences of high debt for investors of Revolution Medicines?

High liabilities can pose a risk for investors of Revolution Medicines, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Revolution Medicines?

Low liabilities mean that Revolution Medicines has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Revolution Medicines affect the company?

An increase in liabilities of Revolution Medicines can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Revolution Medicines affect the company?

A decrease in the liabilities of Revolution Medicines can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Revolution Medicines?

Some factors that can influence the liabilities of Revolution Medicines include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Revolution Medicines so important for investors?

The liabilities of Revolution Medicines are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Revolution Medicines take to modify the liabilities?

To change its liabilities, Revolution Medicines can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Revolution Medicines pay?

Over the past 12 months, Revolution Medicines paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Revolution Medicines is expected to pay a dividend of 0 USD.

What is the dividend yield of Revolution Medicines?

The current dividend yield of Revolution Medicines is .

When does Revolution Medicines pay dividends?

Revolution Medicines pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Revolution Medicines?

Revolution Medicines paid dividends every year for the past 0 years.

What is the dividend of Revolution Medicines?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Revolution Medicines located?

Revolution Medicines is assigned to the 'Health' sector.

Wann musste ich die Aktien von Revolution Medicines kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Revolution Medicines from 10/1/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2025.

When did Revolution Medicines pay the last dividend?

The last dividend was paid out on 10/1/2025.

What was the dividend of Revolution Medicines in the year 2024?

In the year 2024, Revolution Medicines distributed 0 USD as dividends.

In which currency does Revolution Medicines pay out the dividend?

The dividends of Revolution Medicines are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Revolution Medicines

Our stock analysis for Revolution Medicines Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Revolution Medicines Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.